Creatd Files Form S-1, Reports First Quarter 2026 Results and Updates Annual Meeting Schedule
Creatd (OTCQB: CRTD) filed its Q1 2026 report for the period ended March 31, 2026, and an SEC Form S-1 to re-establish SEC reporting. Q1 revenue was about $204k with gross profit about $202k; cash and cash equivalents were about $250k and total current assets about $10.9m. The company also revised its 2026 annual meeting to Aug 3, 2026 (record June 26) and said CEO Jeremy Frommer converted some warrants and preferred into common stock to simplify its capital structure.
How this was made
The 30-second read
Why it matters
The combination of a new SEC registration filing, Q1 financial statements, and warrant/preferred-to-common conversions can re-rate the company’s reporting credibility and investor accessibility, but the disclosed operating numbers are small and results are heavily influenced by non-cash charges.
Market read
Traders may reassess CRTD’s near-term catalyst calendar (investor call/annual meeting) and the regulatory pathway implied by the S-1 filing, while monitoring liquidity/collectability of Flyte-related receivables.
What to watch
Key risk is whether the Flyte disposition and receivables (preferred stock receivable and promissory note) are collectible and how they affect liquidity; the article doesn’t quantify timing or collectability.
Background
Creatd is an OTCQB-listed company attempting to re-establish SEC reporting status via an S-1 filing and pursue an uplisting to a national exchange.
Ticker impact
Creatd filed its Form S-1 to re-establish SEC reporting and reported Q1 cash/assets plus large non-cash charges, signaling a potential uplisting path.
Near-term volatility possible around the S-1 review narrative and the July 7 investor call; direction depends on investor reaction to the capital-structure changes and balance-sheet details.
The article discloses primary regulatory action (S-1 filing) and new quarterly datapoints, but it does not provide guidance or a definitive uplisting timeline beyond stated intent and meeting/call dates.
Market effects
Microcap/OTCQB issuers’ SEC re-entry and uplisting efforts can modestly affect sentiment toward similar capital-structure-light stories, but no direct sector-wide catalyst is provided.
Primarily US-focused (SEC filing, US investor access); limited spillover beyond small-cap OTC sentiment.
Low; the disclosures are US regulatory and company-specific.
Counterpoint
The S-1 and capital-structure simplification may be largely administrative, while operating scale remains tiny (revenue ~$204k) and large stock-based compensation/non-cash items dominate reported results.
Key entities
- companyCreatd, Inc.
OTCQB-listed issuer that filed Form S-1, reported Q1 2026 results, revised annual meeting dates, and converted certain warrants/preferred into common stock.
- personJeremy Frommer
Founder and CEO who completed warrant/preferred conversions and commented on the filings and capital-structure simplification.
- companyCatheter Precision, Inc. (VTAK)
Counterparty in the previously announced disposition of Flyte; Creatd holds a significant equity position and has receivables tied to the disposition.
